ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.
Capstar Special Purpose Acquisition Corp

Capstar Special Purpose Acquisition Corp (CPSR)

7.36
0.00
(0.00%)
마감 05 2월 6:00AM
7.36
0.00
( 0.00% )
시간외 단일가: 9:00AM

포트폴리오 강화: 실시간 토론 및 실행 가능한 거래 아이디어.

주요 통계 및 세부정보

가격
7.36
매수가
-
매도가
-
거래량
-
0.00 일간 변동폭 0.00
0.00 52주 범위 0.00
전일 종가
7.36
개장가
-
최근 거래 시간
마지막 거래 시간
-
평균 볼륨(3m)
-
재정 규모
-
VWAP
-

CPSR 최신 뉴스

Gelesis®, the Maker of Plenity® for Weight Management, Will Debut as a Publicly Traded Company Following the Closing of Its Business Combination with Capstar

Proceeds from this transaction will be used to further support the national launch of Plenity Gelesis will begin trading on the New York Stock Exchange as “GLS” on Friday, January 14, 2022 and...

Gelesis Adds Inogen Co-Founder and Former CFO Ali Bauerlein to Board of Directors and Audit Committee

Ms. Bauerlein brings success in scaling to $300M+ revenue in direct-to-consumer business model and public company execution as Gelesis plans to scale Plenity® to meet growing consumer demand with...

Have Your Cake and Eat It Too: Plenity® Creates Edible Dessert Billboard to Challenge Overly Restrictive Dieting Assumptions

With the prevalence of fad diets, food shaming and resulting guilt, leading health experts advise against villainizing specific food groups and moving to flexibility and...

Gelesis’ FDA-Cleared Weight Management Approach, Plenity®, Now Broadly Available and Leading Nutrition Authority Joy Bauer, MS, RDN, CDN, Joins as Chief Nutrition Officer

Plenity® is transforming weight management with a clinically proven approach made from naturally derived building blocks As Chief Nutrition Officer, Bauer will focus on educating healthcare...

Gelesis Receives $30 Million Plenity Order from Ro

Gelesis’ new commercial manufacturing facility is now producing Plenity® at large scale, enabling supply to meet the growing demand Gelesis announced today that leading U.S. direct-to-patient...

Nature’s Scientific Reports Features Gelesis’ Novel and Foundational Biomimetic Platform for Treating Obesity and Conditions Related to Diet-Induced Gut Damage

New paper describes the first superabsorbent hydrogel technology made from naturally derived building blocks designed to address obesity and gut related conditions by emulating compositional and...

Two Senior Scientific Leaders at Gelesis Awarded Top Industry Honors

Chief Scientific Officer Elaine Chiquette, Pharm.D., Named Among the Top 25 Women Leaders in Biotechnology Elizabeth Pash, MS, RD, LDN, Honored by Academy of Nutrition and Dietetics for...

Gelesis, a Consumer-Focused Biotherapeutics Company & the Maker of Plenity®, to Become a Publicly Traded Company via Merger ...

Building on the successful beta launch of its first product Plenity®, Gelesis aims to transform weight management. Gelesis developed a novel biomimetic therapeutic platform that has yielded...

Capstar Special Purpose Acquisition Corp. Receives Expected Notice from NYSE Regarding Delayed Quarterly Report

Capstar Special Purpose Acquisition Corp. (NYSE:CPSR.U; CPSR; CPSR WS) (the “Company”) today announced that, as expected, on May 25, 2021 it received a notice from the New York Stock Exchange...

Capstar Special Purpose Acquisition Corp. Announces Pricing of Upsized $240 Million Initial Public Offering

AUSTIN, Texas, July 01, 2020 (GLOBE NEWSWIRE) -- Capstar Special Purpose Acquisition Corp. (the “Company”), today announced the pricing of its initial public offering of 24,000,000 units at a...

기간변동변동 %시가고가저가평균 일일 거래량VWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

CPSR - Frequently Asked Questions (FAQ)

What is the current Capstar Special Purpose ... share price?
The current share price of Capstar Special Purpose ... is US$ 7.36
What is the 1 year trading range for Capstar Special Purpose ... share price?
Capstar Special Purpose ... has traded in the range of US$ 0.00 to US$ 0.00 during the past year

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
AAMAA Mission Acquisition Corp
US$ 10.15
(0.00%)
0
AACT.UAres Acquisition Corporation II
US$ 11.32
(0.00%)
0
AACTAres Acquisition Corporation II
US$ 11.02
(0.00%)
0
AAAlcoa Corporation
US$ 36.24
(0.00%)
0
AAgilent Technologies
US$ 147.04
(0.00%)
0
AAMAA Mission Acquisition Corp
US$ 10.15
(0.00%)
0
AACT.UAres Acquisition Corporation II
US$ 11.32
(0.00%)
0
AACTAres Acquisition Corporation II
US$ 11.02
(0.00%)
0
AAAlcoa Corporation
US$ 36.24
(0.00%)
0
AAgilent Technologies
US$ 147.04
(0.00%)
0
AAMAA Mission Acquisition Corp
US$ 10.15
(0.00%)
0
AACT.UAres Acquisition Corporation II
US$ 11.32
(0.00%)
0
AACTAres Acquisition Corporation II
US$ 11.02
(0.00%)
0
AAAlcoa Corporation
US$ 36.24
(0.00%)
0
AAgilent Technologies
US$ 147.04
(0.00%)
0
sab63090 sab63090 6 분 전
EBZ:

The problem is that you have mentioned that even from the sharp advance from that level all the way up to over $14.

Maybe you will be right this time?
AVXL
SkeBallLarry SkeBallLarry 7 분 전
Jack Poso said USAID was just the beginning of what will be uncovered. You will see horrors beyond your wildest imagination"

https://x.com/JackPosobiec/status/1886903503806677488
nowwhat2 nowwhat2 7 분 전
https://investorshub.advfn.com/uimage/uploads/2025/2/5/ukuikxrp_@_5_6m_1am_DIAG_HORIZ_HARD.jpg





https://investorshub.advfn.com/uimage/uploads/2025/2/5/xleqexrp_@_1_6m_1212pm_horiz_diag_narrate_lesson.jpg





XRPUSD
weedtrader420 weedtrader420 7 분 전
🎿RP ☝️😶‍🌫️☝️
XRPUSD
SkeBallLarry SkeBallLarry 8 분 전
Jack Poso said USAID was just the beginning of what will be uncovered. You will see horrors beyond your wildest imagination"

https://x.com/JackPosobiec/status/1886903503806677488
SkeBallLarry SkeBallLarry 9 분 전
Jack Poso said USAID was just the beginning of what will be uncovered. You will see horrors beyond your wildest imagination"

https://x.com/JackPosobiec/status/1886903503806677488
sab63090 sab63090 12 분 전
Hosai

This seems to be a timely request for some hiring based on the downsizing one would expect at the FDA and some of the Big Pharma reductions in staff.
AVXL
beachhyena beachhyena 20 분 전
You will also see Autologous Dendritic Cell Vaccine - line 76.
NWBO
sab63090 sab63090 22 분 전
Steady

I will just mention that the Tulip Craze, Bitcoin, and Tesla are examples of how high greed can go!

The downside is only 100%, the upside is unlimited.
AVXL
TommyJ7651 TommyJ7651 24 분 전
Just something to take note of here. I have been following the comments received for Springpole on the Federal project website/portal:

https://iaac-aeic.gc.ca/050/evaluations/proj/80149/contributions

There are have been many letters of support coming in for Springpole f
FFMGF
sab63090 sab63090 29 분 전
Tom:
Your experience of more than 14 years sure has me beat by more than 10 1/2 years. Logical support levels have been consistently broken and lead me to believe that the short sellers are still in control (along with the market makers making $$$ in their partnership with them).
AVXL
gotmilk gotmilk 30 분 전
Materials to build artificial reefs into the Mediterranean Sea.

Concrete

To be responsible for disposing of unexploded munitions...
Rebuilding Gaza into a mecca for jobs and tourism...
...to turn it into “The Riviera of the Middle East.”

ht
nowwhat2 nowwhat2 35 분 전
February 3rd and 4th https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175749348

https://investorshub.advfn.com/uimage/uploads/2025/2/5/vamecrace_@_3_5y_downgap_chan.jpg





Tuesday Feb. the 4th
https://investorshub.advfn.
RACE
meshcan meshcan 38 분 전
$215M and with that only ELTP can be over $2 pps
ELTP
Stino2 Stino2 48 분 전
The following company's did a RS and have sunk very deep: BNGO, MULLEN, JAGX, ADAP, OCGN, NKLA etc....🤑
ADAP BNGO JAGX
Stino2 Stino2 53 분 전
25% I have left and also this company doesn't answer their mails!!😪
TNXP
Stino2 Stino2 54 분 전
We wil see today???
TNXP
Biotechotcguy Biotechotcguy 59 분 전
This is getting juicy!!!!!
DROR
infamous infamous 1 시간 전
so much for compliance again. what a trap this is
GCTK
misterfishman misterfishman 1 시간 전
Agreed.
IGPK
bbotcs bbotcs 1 시간 전
al44: That should result in a lawsuit.
bbotcs bbotcs 1 시간 전
lj: SMCI
Has it finally bottomed, or will it retest the recent low of $25 and change? Stay tuned.
Thank you for mentioning the AMD calls. Will check them out today (Wednesday).
AMD SMCI
leavetheguntakethecannolis leavetheguntakethecannolis 1 시간 전
A reminder for all.

https://www.beam-med.com/

Brain

Epilepsy is the most prevalent serious neurologic condition in the world, affecting about 70 million people. Unfortunately, 30%-40% of those patients are afflicted with drug resistant epilepsy, meaning t
IPIX
muee88 muee88 1 시간 전
You’re welcome, no problem at all
NWBO

최근 히스토리

Delayed Upgrade Clock